U.S. agrees to pay Sanofi and GSK $2.1 billion for 100 million doses of coronavirus vaccine
The U.S. government will pay drugmaker Sanofi and GlaxoSmithKline up to $2.1 billion to develop and deliver 100 million doses of their potential coronavirus vaccine, the companies announced Friday. More than half of the $1.5 billion will be used to support further development of the vaccine, including clinical trials.
The rest will be for manufacturing and delivery of the 100 million doses,
the companies said. The U.S. will have the option to order an additional 500 million doses, they said.
Public health officials say there is no returning to “normal”
until there is a vaccine against the coronavirus, which has infected
more than 17 million people worldwide and killed at least 667,808, according to data compiled by Johns Hopkins University.
More than 150 vaccines are under development, according to the World Health Organization, with 25 already in clinical trials.
Comment: I do not think a vaccine will work, and our money is better spent on treatment avenues.